...
首页> 外文期刊>Infectious diseases in clinical practice: IDCP >Poor Outcome of Central Nervous System Invasive Aspergillosis in HIV Infection Despite Galactomannan-Based Diagnosis-A Case Series and Literature Review
【24h】

Poor Outcome of Central Nervous System Invasive Aspergillosis in HIV Infection Despite Galactomannan-Based Diagnosis-A Case Series and Literature Review

机译:尽管基于半乳甘露聚糖的诊断,中枢神经系统侵袭性曲霉病在HIV感染中的不良结果-病例系列和文献综述

获取原文
获取原文并翻译 | 示例

摘要

Invasive aspergillosis is recognized as a devastating disease in some immunocompromised populations, although it is not accepted as an established complication of human immunodeficiency virus/acquired immunodeficiency syndrome under the World Health Organization's staging criteria. Complications affecting the central nervous system are rarely reported, which may relate to a lack of adequate diagnostic tests. We report the use of the galactomannan Platelia assay in 3 patients with invasive cerebral infection and advanced human immunodeficiency virus, as defined by the World Health Organization, with CD4 T-lymphocyte counts of less than 350 cells/muL. The clinical use of the assay in early detection, particularly when used in a serial fashion, is compared to standard microbiological techniques. The limitations of the current assay are described in the context of future diagnostic approaches, such as sampling of cerebrospinal fluid and bronchoalveolar lavage specimens and the use of nucleic acid techniques.
机译:尽管在世界卫生组织的分期标准下,浸润性曲霉病并未被公认是人类免疫缺陷病毒/后天免疫缺陷综合症的既定并发症,但在一些免疫功能低下的人群中被认为是破坏性疾病。很少有影响中枢神经系统的并发症报道,这可能与缺乏足够的诊断测试有关。我们报告了半乳甘露聚糖Platelia检测在3名侵袭性脑感染和晚期人类免疫缺陷病毒患者中的使用,如世界卫生组织所定义,CD4 T淋巴细胞计数少于350个细胞/μL。将该方法在早期检测中的临床应用(尤其是按系列使用时)与标准微生物技术进行了比较。当前测定的局限性是在未来的诊断方法中描述的,例如脑脊液和支气管肺泡灌洗标本的采样以及核酸技术的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号